Clinical Trial

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

Completed
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to investigate the usability of auto-captioning glasses for adults diagnosed with NF2-related schwannomatosis and loss of hearing. The primary objective of the study is to determine the feasibility and acceptability of auto-captioning glasses in this population. Participants will be asked to: * Use the glasses at their discretion for 12 weeks * Report their feedback at 3 and 12 week timepoints via online surveys and remote qualitative interviews
Protocol Amendment History 5 changes
critical Trial completed 2026-08-11
notable Primary completion moved earlier: 2026-12 -> 2026-08-06 2026-08-11
minor Completion moved earlier: 2026-12 -> 2026-08-06 2026-08-11
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-04-29
notable Enrollment reduced: 20 -> 18 participants 2026-04-29
Trial Details
NCT Number NCT07420751
Lead Sponsor Massachusetts General Hospital
Conditions NF2-related Schwannomatosis
Enrollment 18 participants
Start Date 2026-02-19
Primary Completion 2026-08-06 (estimated)
Study Completion 2026-08-06 (estimated)
Updated on ClinicalTrials.gov 2026-08-10